RecruitingPhase 2NCT06998043
Study With Phage for CF Subjects With Pseudomonas Lung Infection
Studying Cystic fibrosis-gastritis-megaloblastic anemia syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- BiomX Ltd
- Principal Investigator
- Urania Rappo, MDBiomX, Inc.
- Intervention
- BX004(biological)
- Enrollment
- 63 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2025 – 2026
Study locations (14)
- University of Alabama at Birmingham, Birmingham, Alabama, United States
- Providence Alaska Medical Center, Anchorage, Alaska, United States
- University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
- Stanford University, Palo Alto, California, United States
- University of California San Francisco, San Francisco, California, United States
- National Jewish Health, Denver, Colorado, United States
- Joe DiMaggio Children's Health, Hollywood, Florida, United States
- Central Florida Pulmonary Group, Orlando, Florida, United States
- Avanza Medical Center, Pensacola, Florida, United States
- Rutgers, Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States
- New York Medical College, Hawthorne, New York, United States
- Northwell Health, New York, New York, United States
- Vanderbilt University Medical Center, Nashville, Tennessee, United States
- University of Utah, Salt Lake City, Utah, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06998043 on ClinicalTrials.govOther trials for Cystic fibrosis-gastritis-megaloblastic anemia syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07071324CF Wellness ProgramJohns Hopkins University
- RECRUITINGNANCT07223255Gastrointestinal Response of Pediatric Cystic Fibrosis Patients on Mediterranean DietDartmouth-Hitchcock Medical Center
- RECRUITINGNANCT07031323OnTrackCF: Engagement, Feasibility, and Acceptability StudyBoston Children's Hospital
- ACTIVE NOT RECRUITINGNCT07147803Sleep Quality in Patients With Non-cystic Fibrosis BronchiectasisAssiut University
- RECRUITINGNCT06683092Restarting Triple Therapy With Robust Monitoring for Adverse Events (RETRIAL)Boston Children's Hospital
- RECRUITINGPHASE2NCT06559150A Phase II Study of Ensifentrine in Non-Cystic Fibrosis BronchiectasisVerona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA
- RECRUITINGPHASE4NCT05704036Estrogen Supplementation and Bone Health in Women With CFJohns Hopkins University
- RECRUITINGNCT06274840COVID-19 Antibody Responses In Cystic FibrosisPilar Azevedo
See all trials for Cystic fibrosis-gastritis-megaloblastic anemia syndrome →